Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.LifeCycle Pharma launches cholesterol drug in US
Fenoglide will be the lowest dose of fenofibrate available for patients. Fenoglide will be offered in 40mg and 120mg strength tablets. Fenoglide utilizes LCP’s unique MeltDose technology, a
Fenoglide will be the lowest dose of fenofibrate available for patients. Fenoglide will be offered in 40mg and 120mg strength tablets. Fenoglide utilizes LCP’s unique MeltDose technology, a
Under terms of the agreement, Quest Diagnostics will generally have the exclusive right to provide full-service medical screening and diagnostic testing of life insurance candidates, and related administrative
The study investigated the response of the T-SPOT.TB assay in 33 subjects with culture confirmed TB. T-SPOT.TB was positive in 83% of the subjects who had received less
The drops have already been launched in Spain, Portugal, the Czech Republic and Canada and it is expected that they will be launched in Jordan and Mexico during
The continuation of the trial following this interim analysis triggers a milestone payment to Oxford BioMedica of E10 million. TroVax is Oxford BioMedica’s novel cancer immunotherapy product, which
RBT has developed a proprietary method for skin whitening through the use of an enzyme derived from a harmless fungus. The RBT product can also be used to
As of February 20, 2008, shares of Visicu common stock will no longer be listed on the NASDAQ.
XELR8 will issue 500,000 unregistered common shares at $1 per share and 300,000 new warrants exercisable at $1.50 per share. In addition, as part of the new funding,
Under the terms of the agreement, OXiGENE will determine the exact timing and amount of any CEFF financings, subject to certain conditions. OXiGENE can access up to $40
As previously announced, each unit will be comprised of one common share of the company and one half of one share purchase warrant. Each whole warrant will entitle